FDA Hits Guardian Drug for Lack of Quality Controls, Secure Data Post author:Sam Post published:April 11, 2017 Post category:Drug Industry Daily The FDA cited Guardian Drug Company over quality and data storage issues. Source: Drug Industry Daily You Might Also Like Proposed NJ Rule to Limit Drugmaker Payment to Doctors Could Hurt Drug Development, ACRO Warns October 25, 2017 Civica and Partners Plan on Providing Affordable Insulin Drugs March 3, 2022 WHO Considers Ways to Boost Access, Cut Prices for Cancer Drugs November 30, 2018
Proposed NJ Rule to Limit Drugmaker Payment to Doctors Could Hurt Drug Development, ACRO Warns October 25, 2017